FIXX - Homology Medicines, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5820.3M
Enterprise Value 3610.15M
Trailing P/E N/A
Forward P/E 1-7.83
PEG Ratio (5 yr expected) 10.85
Price/Sales (ttm)290.37
Price/Book (mrq)4.05
Enterprise Value/Revenue 3215.98
Enterprise Value/EBITDA 6-8.28

Trading Information

Stock Price History

Beta (3Y Monthly) N/A
52-Week Change 3-7.79%
S&P500 52-Week Change 39.10%
52 Week High 331.80
52 Week Low 315.07
50-Day Moving Average 320.49
200-Day Moving Average 323.33

Share Statistics

Avg Vol (3 month) 3290.55k
Avg Vol (10 day) 3257.79k
Shares Outstanding 543.49M
Float 20.13M
% Held by Insiders 18.76%
% Held by Institutions 181.69%
Shares Short (May 31, 2019) 41.85M
Short Ratio (May 31, 2019) 49.36
Short % of Float (May 31, 2019) 47.70%
Short % of Shares Outstanding (May 31, 2019) 44.25%
Shares Short (prior month Apr 30, 2019) 42.02M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)-2,689.95%

Management Effectiveness

Return on Assets (ttm)-26.23%
Return on Equity (ttm)-53.98%

Income Statement

Revenue (ttm)2.83M
Revenue Per Share (ttm)0.08
Quarterly Revenue Growth (yoy)-76.10%
Gross Profit (ttm)-44.26M
EBITDA -73.66M
Net Income Avi to Common (ttm)-70.85M
Diluted EPS (ttm)-1.90
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)187.97M
Total Cash Per Share (mrq)4.32
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)10.80
Book Value Per Share (mrq)4.66

Cash Flow Statement

Operating Cash Flow (ttm)-49.39M
Levered Free Cash Flow (ttm)-66.7M